相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SGC-AAK1-1: A Chemical Probe Targeting AAK1 and BMP2K
Carrow Wells et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
A phase I study of CX-4945 administered orally twice daily to patients with advanced basal cell carcinoma.
Zeynep Eroglu et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Mehdi Bouhaddou et al.
CELL (2020)
DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity
Martin Schroeder et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Optimization of pyrazolo[1,5-a]pyrimidines lead to the identification of a highly selective casein kinase 2 inhibitor
Andreas Kraemer et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Death-associated protein kinase (DAPK) family modulators: Current and future therapeutic outcomes
Ahmed Karam Farag et al.
MEDICINAL RESEARCH REVIEWS (2019)
SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK)
Christopher R. M. Asquith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
[b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors
Christian Lechner et al.
MOLECULES (2019)
Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression
Sourav Banerjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells
Giovanni Di Maira et al.
ONCOGENESIS (2019)
Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinom
Kais Zakharia et al.
TRANSLATIONAL ONCOLOGY (2019)
Novel Functions of Death-Associated Protein Kinases through Mitogen-Activated Protein Kinase-Related Signals
Mohamed Elbadawy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement
James D. Vasta et al.
CELL CHEMICAL BIOLOGY (2018)
The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy
Fatima Ardito et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Identification of a Druggable Pathway Controlling Glioblastoma Invasiveness
Nora Pencheva et al.
CELL REPORTS (2017)
A Selective Biligand Inhibitor of CK2 Increases Caspase-3 Activity in Cancer Cells and Inhibits Platelet Aggregation
Hedi Rahnel et al.
CHEMMEDCHEM (2017)
CK2-An Emerging Target for Neurological and Psychiatric Disorders
Julia Castello et al.
PHARMACEUTICALS (2017)
Protein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks
Teresa Nunez de Villavicencio-Diaz et al.
PHARMACEUTICALS (2017)
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
Melissa M. J. Chua et al.
PHARMACEUTICALS (2017)
The use of novel selectivity metrics in kinase research
Nicolas Bosc et al.
BMC BIOINFORMATICS (2017)
Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer Cells
Adam J. Rabalski et al.
CLINICAL CANCER RESEARCH (2016)
Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer's disease pathology
Andrea F. N. Rosenberger et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo
James E. Dowling et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
mTORC1 and CK2 coordinate ternary and eIF4F complex assembly
Valentina Gandin et al.
NATURE COMMUNICATIONS (2016)
Leveraging the Pre-DFG Residue Thr-406 To Obtain High Kinase Selectivity in an Aminopyrazole-Type PAK1 Inhibitor Series
Joachim Rudolph et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies
Hee J. Chon et al.
FRONTIERS IN PHARMACOLOGY (2015)
Identification of a Novel Function of CX-4945 as a Splicing Regulator
Hyeongki Kim et al.
PLOS ONE (2014)
Targeting Protein Kinase CK2 Suppresses Prosurvival Signaling Pathways and Growth of Glioblastoma
Ying Zheng et al.
CLINICAL CANCER RESEARCH (2013)
Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195
Yunsong Tong et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo
James E. Dowling et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
A Novel Mechanism by Which Small Molecule Inhibitors Induce the DFG Flip in Aurora A
Mathew P. Martin et al.
ACS CHEMICAL BIOLOGY (2012)
Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight
Graziano Lolli et al.
BIOCHEMISTRY (2012)
Effects of the CK2 Inhibitors CX-4945 and CX-5011 on Drug-Resistant Cells
Sofia Zanin et al.
PLOS ONE (2012)
Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization
James E. Dowling et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer
Roberto Battistutta et al.
BIOCHEMISTRY (2011)
Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2
Andriy G. Golub et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthetic Reversal of Epigenetic Silencing
Karmella A. Haynes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer
Fabrice Pierre et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Unbiased Functional Proteomics Strategy for Protein Kinase Inhibitor Validation and Identification of bona fide Protein Kinase Substrates: Application to Identification of EEF1D as a Substrate for CK2
Laszlo Gyenis et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
Protein Kinases CK1 and CK2 as New Targets for Neurodegenerative Diseases
Daniel I. Perez et al.
MEDICINAL RESEARCH REVIEWS (2011)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
Adam Siddiqui-Jain et al.
CANCER RESEARCH (2010)
Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis
Mauro Salvi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
CK2: A key player in cancer biology
J. H. Trembley et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Masato Hasegawa et al.
ANNALS OF NEUROLOGY (2008)
The selectivity of inhibitors of protein kinase CK2: an update
Mario A. Pagano et al.
BIOCHEMICAL JOURNAL (2008)
Localization of CKII β subunits in Lewy bodies of Parkinson's disease
Myung Yi Ryu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Model preparation in MOLREP and examples of model improvement using X-ray data
Andrey A. Lebedev et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2008)
Protein kinase CK2α as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia
Jin Seok Kim et al.
CLINICAL CANCER RESEARCH (2007)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Protein kinase CK2 phosphorylates and upregulates Akt/PKB
G Di Maira et al.
CELL DEATH AND DIFFERENTIATION (2005)
REFMAC5 dictionary:: organization of prior chemical knowledge and guidelines for its use
AA Vagin et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
One-thousand-and-one substrates of protein kinase CK2?
F Meggio et al.
FASEB JOURNAL (2003)
Protein kinase CK2: structure, regulation and role in cellular decisions of life and death
DW Litchfield
BIOCHEMICAL JOURNAL (2003)
Subcellular localization of protein kinase CK2 - A key to its function?
M Faust et al.
CELL AND TISSUE RESEARCH (2000)
分享论文
